Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending
Biologics
Clinical Development
Ophthalmology
Cell & Gene Therapy
Fierce 50
Special Report
Awards Gala
Awards
Outsourcing Awards
Innovation Awards
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Subscribe
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending
Biologics
Clinical Development
Ophthalmology
Cell & Gene Therapy
Fierce 50
Special Report
Awards Gala
Awards
Outsourcing Awards
Innovation Awards
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Charles River
CRO
Charles River sells CDMO and discovery assets in strategic pivot
The CRO is offloading its contract manufacturing operation and some of its European discovery services, which brought in $287 million last year.
Darren Incorvaia
Feb 25, 2026 1:54pm
Charles River's incoming CEO talks R&D processes, reorg goals
Jan 28, 2026 12:58pm
Former Roche oncology head turns to Tubulis—Chutes & Ladders
Jan 9, 2026 8:30am
Longtime Charles River CEO to retire; COO will take the helm
Jan 8, 2026 12:54pm
Charles River lays off 70 staffers as strategic shift begins
Nov 14, 2025 4:40pm
Charles River to cut costs, shift direction as revenue slides
Nov 5, 2025 12:54pm
